Drug shortages homepage

Welcome to Drug Shortages Canada, the website for reporting drug shortages and discontinuations in Canada. The Food and Drug Regulations require drug sellers to report when they are not able to meet demand for a product or when they stop selling a product. Information about the website and the regulations can be found on the About & Resources Page.

A shortage means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug is unable to meet the demand for the drug.

A discontinuation means, in respect of a drug, a situation in which the manufacturer to whom a document was issued under subsection C.01.014.2(1) that sets out the drug identification number assigned for the drug, permanently ceases the sale of the drug.

Tier 3 drug shortages are those that have the greatest potential impact on Canada's drug supply and health care system. Impact is based on low availability of alternative supplies, ingredients or therapies. The Tier Assignment Committee (TAC), composed of federal and provincial/territorial governments, healthcare professionals, and industry stakeholders, makes recommendations on the tier assignment of drug shortages. The TAC assessment includes:

  • a review of the information gathered on the shortage issue, and
  • a thorough discussion on its potential impact and next steps.

Below are the newest and most recently updated Shortage and Discontinuation reports. Alternatively, please visit the Tier 3 page to see current Tier 3 Drug Shortages and associated shortage or discontinuation reports.

Drug pills

LEGEND

!!T3 denotes an actual Tier 3 shortage/discontinuation

!T3 denotes an anticipated Tier 3 shortage/discontinuation

Shortage Reports

Brand name Company Name Status Strength Update Date Updated View Report
!!T3 AMIODARONE HYDROCHLORIDE FOR INJECTION SANDOZ CANADA INCORPORATED Actual shortage 50MG Updated Report 2022-11-28 173394
VERAPAMIL HYDROCHLORIDE INJECTION USP SANDOZ CANADA INCORPORATED Actual shortage 2.5MG New Report 2022-11-28 175970
SANDOZ VALSARTAN HCT SANDOZ CANADA INCORPORATED Actual shortage 12.5MG 320MG Updated Report 2022-11-28 174912
!!T3 AMOXICILLIN SANIS HEALTH INC Actual shortage 250MG Updated Report 2022-11-28 173943
SANDOZ VALSARTAN HCT SANDOZ CANADA INCORPORATED Actual shortage 25MG 320MG Updated Report 2022-11-28 174915
SANDOZ SOLIFENACIN SANDOZ CANADA INCORPORATED Actual shortage 5MG Updated Report 2022-11-28 175009
!!T3 SANDOZ PREDNISOLONE SANDOZ CANADA INCORPORATED Actual shortage 1% Updated Report 2022-11-28 165796
SANDOZ PIRFENIDONE TABLETS SANDOZ CANADA INCORPORATED Actual shortage 267MG Updated Report 2022-11-28 174985
NALOXONE HCL INJECTION - 1MG/ML USP SANDOZ CANADA INCORPORATED Actual shortage 1MG Updated Report 2022-11-28 172174
MORPHINE HP 50 - 50MG/ML USP SANDOZ CANADA INCORPORATED Actual shortage 50MG Updated Report 2022-11-28 169026

Discontinuation Reports

Brand name Company Name Status Strength Update Date Updated View Report
PMS-FENTANYL MTX PHARMASCIENCE INC Discontinued 12MCG Updated Report 2022-11-25 165397
PMS-FENTANYL MTX PHARMASCIENCE INC Discontinued 12MCG Updated Report 2022-11-25 165462
HIBERIX GLAXOSMITHKLINE INC To be discontinued 10MCG New Report 2022-11-18 175258
!!T3 INTEGRILIN MERCK CANADA INC Discontinued 0.75MG Updated Report 2022-11-18 155790
!!T3 INTEGRILIN MERCK CANADA INC Discontinued 2MG Updated Report 2022-11-18 155794